Cytek Biosciences Inc
NASDAQ:CTKB
Cytek Biosciences Inc
NASDAQ:CTKB
Price:
6.42 USD
3.22%
Market Closed
Updated:
May 7, 2024
Cytek Biosciences Inc
Cash from Operating Activities
|
Cytek Biosciences Inc
Cash from Operating Activities Peer Comparison
Comparables:
TMO
DHR
WST
A
IQV
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Cytek Biosciences Inc
NASDAQ:CTKB
|
Cash from Operating Activities
$5.3m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash from Operating Activities
$8.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
|
Danaher Corp
NYSE:DHR
|
Cash from Operating Activities
$7B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
12%
|
CAGR 10-Years
7%
|
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Cash from Operating Activities
$756.6m
|
CAGR 3-Years
14%
|
CAGR 5-Years
21%
|
CAGR 10-Years
14%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Cash from Operating Activities
$2B
|
CAGR 3-Years
17%
|
CAGR 5-Years
13%
|
CAGR 10-Years
6%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash from Operating Activities
$2.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
11%
|
CAGR 10-Years
19%
|
See Also
What is Cytek Biosciences Inc's Cash from Operating Activities?
Cash from Operating Activities
5.3m
USD
5.3m
USD
Based on the financial report for Dec 31, 2023, Cytek Biosciences Inc's Cash from Operating Activities amounts to 5.3m USD.
What is Cytek Biosciences Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
-30%
-30%
The average annual Cash from Operating Activities growth rates for Cytek Biosciences Inc have been -30% over the past three years .
You don't have any saved screeners yet
